For research use only. Not for therapeutic Use.
CP26（Cat No.:I025133）is a selective inhibitor of the protein kinase CK2, which plays a crucial role in regulating cell growth, survival, and proliferation. By inhibiting CK2, CP26 disrupts signaling pathways involved in cancer progression, inflammation, and other diseases associated with abnormal kinase activity. This small molecule inhibitor has shown promise in preclinical studies for its potential to suppress tumor growth and enhance the efficacy of other cancer therapies. CP26’s specificity for CK2 makes it an attractive candidate for targeted therapeutic strategies in oncology and inflammatory conditions.
| CAS Number | 500285-30-3 |
| Synonyms | 1-methyl-4-[(2,3,4,5-tetrachlorocyclopenta-2,4-dien-1-ylidene)methyl]benzene |
| Molecular Formula | C13H8Cl4 |
| Purity | ≥95% |
| IUPAC Name | 1-methyl-4-[(2,3,4,5-tetrachlorocyclopenta-2,4-dien-1-ylidene)methyl]benzene |
| InChI | InChI=1S/C13H8Cl4/c1-7-2-4-8(5-3-7)6-9-10(14)12(16)13(17)11(9)15/h2-6H,1H3 |
| InChIKey | GLCNSQWOANYMNW-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(C=C1)C=C2C(=C(C(=C2Cl)Cl)Cl)Cl |
